Shauna L. Hillman

3.8k total citations · 2 hit papers
57 papers, 2.8k citations indexed

About

Shauna L. Hillman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Shauna L. Hillman has authored 57 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Shauna L. Hillman's work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (15 papers). Shauna L. Hillman is often cited by papers focused on Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (15 papers). Shauna L. Hillman collaborates with scholars based in United States, Canada and South Africa. Shauna L. Hillman's co-authors include James R. Jett, Sumithra J. Mandrekar, Stephen J. Swensen, David E. Midthun, Thomas E. Hartman, Gregory L. Aughenbaugh, Anne-Marie Sykes, Randolph S. Marks, Jeff A. Sloan and Katie L. Allen and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shauna L. Hillman

54 papers receiving 2.7k citations

Hit Papers

Screening for Lung Cancer with Low-Dose Spiral Computed T... 2002 2026 2010 2018 2002 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Screening for Lung Cancer with Low-Dose Spiral Computed Tomography
    2002 522 citations Stephen J. Swensen, James R. Jett et al. American Journal of Respiratory and Critical Care Medicine profile →
  2. CT Screening for Lung Cancer: Five-year Prospective Experience
    2005 481 citations Stephen J. Swensen, James R. Jett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shauna L. Hillman United States 24 2.0k 1.1k 735 345 314 57 2.8k
Ramesh Rengan United States 33 2.2k 1.1× 914 0.8× 1.3k 1.7× 289 0.8× 274 0.9× 157 3.5k
Ruth Swann United Kingdom 22 1.6k 0.8× 1.1k 1.0× 472 0.6× 148 0.4× 540 1.7× 44 2.7k
Anne‐Pascale Meert Belgium 23 1.4k 0.7× 1.2k 1.0× 503 0.7× 582 1.7× 529 1.7× 127 2.7k
Madelon Pijls-Johannesma Netherlands 31 1.8k 0.9× 970 0.9× 595 0.8× 535 1.6× 188 0.6× 49 2.9k
P. Fournel France 26 3.4k 1.7× 2.4k 2.1× 560 0.8× 492 1.4× 455 1.4× 159 4.6k
Kyounghwa Bae United States 28 3.4k 1.7× 980 0.9× 477 0.6× 239 0.7× 357 1.1× 46 4.2k
Gavin Wright Australia 27 2.1k 1.1× 1.3k 1.1× 402 0.5× 141 0.4× 463 1.5× 128 3.0k
Thomas A. Hensing United States 26 1.6k 0.8× 1.7k 1.5× 225 0.3× 365 1.1× 670 2.1× 83 2.9k
Takashi Eguchi Japan 28 1.5k 0.8× 840 0.7× 446 0.6× 167 0.5× 667 2.1× 147 2.8k
Jonathan E. Dowell United States 24 1.4k 0.7× 1.1k 1.0× 256 0.3× 135 0.4× 461 1.5× 91 2.5k

Countries citing papers authored by Shauna L. Hillman

Since Specialization
Citations

This map shows the geographic impact of Shauna L. Hillman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shauna L. Hillman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shauna L. Hillman more than expected).

Fields of papers citing papers by Shauna L. Hillman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shauna L. Hillman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shauna L. Hillman. The network helps show where Shauna L. Hillman may publish in the future.

Co-authorship network of co-authors of Shauna L. Hillman

This figure shows the co-authorship network connecting the top 25 collaborators of Shauna L. Hillman. A scholar is included among the top collaborators of Shauna L. Hillman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shauna L. Hillman. Shauna L. Hillman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
George, Suzanne, Nancy Campbell, Shauna L. Hillman, et al.. (2024). Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials. Cancer. 131(1). e35528–e35528. 5 indexed citations
3.
Sands, Jacob, Sumithra J. Mandrekar, David Kozono, et al.. (2021). Integration of Immunotherapy into Adjuvant Therapy for Resected Non-Small-Cell Lung Cancer: ALCHEMIST Chemo-Io (ACCIO). Immunotherapy. 13(9). 727–734. 17 indexed citations
4.
Boughey, Judy C., Rebecca A. Snyder, Olga Kantor, et al.. (2021). Impact of the COVID-19 Pandemic on Cancer Clinical Trials. Annals of Surgical Oncology. 28(12). 7311–7316. 24 indexed citations
5.
Sands, Jacob, Sumithra J. Mandrekar, Geoffrey R. Oxnard, et al.. (2020). ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.. Journal of Clinical Oncology. 38(15_suppl). TPS9077–TPS9077. 23 indexed citations
6.
Ross, Helen J., Steven E. Schild, Shauna L. Hillman, et al.. (2017). (S014) Long-Terms Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance). International Journal of Radiation Oncology*Biology*Physics. 98(2). E5–E5.
7.
Fernando, Hiran C., Rodney J. Landreneau, Sumithra J. Mandrekar, et al.. (2014). Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from the ACOSOG Z4032 (Alliance) multicenter randomized trial. Journal of Thoracic and Cardiovascular Surgery. 149(3). 718–726. 47 indexed citations
8.
An, Ming-Wen, Sumithra J. Mandrekar, Megan E. Branda, et al.. (2011). Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials. Clinical Cancer Research. 17(20). 6592–6599. 22 indexed citations
9.
Fernando, Hiran C., Rodney J. Landreneau, Sumithra J. Mandrekar, et al.. (2011). The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: Preliminary results from the American College of Surgeons Oncology Group Z4032 Trial. Journal of Thoracic and Cardiovascular Surgery. 142(3). 554–562. 27 indexed citations
10.
Fernando, Hiran C., Rodney J. Landreneau, Sumithra J. Mandrekar, et al.. (2011). Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non–small cell lung cancer: Results from a multicenter phase III study. Journal of Thoracic and Cardiovascular Surgery. 142(5). 1143–1151. 52 indexed citations
11.
Dy, Grace K., Shauna L. Hillman, Kendrith M. Rowland, et al.. (2010). A front‐line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer. Cancer. 116(24). 5686–5693. 35 indexed citations
12.
Mandrekar, Sumithra J., Yingwei Qi, Shauna L. Hillman, et al.. (2010). Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(1). 3–9. 32 indexed citations
13.
Hillman, Shauna L. & Daniel J. Sargent. (2010). Reply to M.A. Rosen et al. Journal of Clinical Oncology. 28(10). e161–e161. 1 indexed citations
14.
Mandrekar, Sumithra J., Steven E. Schild, Shauna L. Hillman, et al.. (2006). A prognostic model for advanced stage nonsmall cell lung cancer. Cancer. 107(4). 781–792. 96 indexed citations
15.
Molina, Julian R., Daniel A. Nikcevich, Shauna L. Hillman, et al.. (2006). A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer. Cancer Investigation. 24(4). 382–389. 3 indexed citations
16.
Molina, Julian R., James R. Jett, Nathan R. Foster, et al.. (2006). Phase II NCCTG Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer. American Journal of Clinical Oncology. 29(3). 246–251. 5 indexed citations
17.
Jatoi, Aminah, Shauna L. Hillman, Philip J. Stella, et al.. (2005). Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group. Journal of Clinical Oncology. 23(36). 9113–9119. 100 indexed citations
18.
Schild, Steven E., James A. Bonner, Thomas G. Shanahan, et al.. (2004). Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 59(4). 943–951. 114 indexed citations
19.
Jatoi, Aminah, Shauna L. Hillman, Philip J. Stella, et al.. (2003). Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Supportive Care in Cancer. 11(7). 460–464. 17 indexed citations
20.
Swensen, Stephen J., James R. Jett, Jeff A. Sloan, et al.. (2002). Screening for Lung Cancer with Low-Dose Spiral Computed Tomography. American Journal of Respiratory and Critical Care Medicine. 165(4). 508–513. 522 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramesh Rengan Breakdown of academic impact, for papers by Ruth Swann Breakdown of academic impact, for papers by Anne‐Pascale Meert Breakdown of academic impact, for papers by Madelon Pijls-Johannesma Breakdown of academic impact, for papers by P. Fournel Breakdown of academic impact, for papers by Kyounghwa Bae Breakdown of academic impact, for papers by Gavin Wright Breakdown of academic impact, for papers by Thomas A. Hensing Breakdown of academic impact, for papers by Takashi Eguchi Breakdown of academic impact, for papers by Jonathan E. Dowell
Rankless by CCL
2026